Loading...
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to Ryan T. Fischer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Fischer, Ryan

PropertyValue
research overview Dr. Fischer is a board-certified Pediatric Gastroenterologist and Transplant Hepatologist at Children's Mercy Hospital in Kansas City. He has a strong interest in translational research related to liver disease and transplantation, and novel therapeutics to treat disordered inflammation in the liver. Dr. Fischer’s background in the lab includes basic research in dendritic cell biology, antigen presentation and cell-based immunotherapy. In collaboration with the University of Kansas’s Department of Microbiology, Immunology and Genetics, he is working to harness the potential of regulatory T cells for the modulation of liver allograft rejection. Clinically, his focus is on the diagnosis and treatment of liver disease in children, with a great deal of time devoted to children that need or have undergone liver transplantation. The hepatology team specializes in fatty liver disease, drug-induced liver injury, progressive liver fibrosis, and liver disease related to congenital heart disease.

One or more keywords matched the following items that are connected to Fischer, Ryan

Item TypeName
Concept B-Lymphocytes
Concept Bone Marrow Cells
Concept Cells, Cultured
Concept Dendritic Cells
Concept Killer Cells, Natural
Concept T-Lymphocytes
Concept CD4-Positive T-Lymphocytes
Concept CD8-Positive T-Lymphocytes
Concept Epitopes, T-Lymphocyte
Concept Myeloid Cells
Concept T-Lymphocytes, Regulatory
Academic Article Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Academic Article Use of rapamycin in the induction of tolerogenic dendritic cells.
Academic Article Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.
Academic Article Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo.
Academic Article Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency.
Academic Article Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells.
Academic Article Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?
Academic Article Humoral and cellular response to the COVID-19 vaccine in immunocompromised children.

Search Criteria
  • T Lymphocytes